The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel framework to grade the quality of surrogate endpoints at the trial level: An analysis of surrogate endpoints used in colorectal cancer trials.
 
Brendan Chia
No Relationships to Disclose
 
Carmen Allegra
No Relationships to Disclose
 
Smitha Krishnamurthi
Consulting or Advisory Role - Agenus; Bristol-Myers Squibb; Takeda
Research Funding - Agenus (Inst); Aravive (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for two chapters I have written in UptoDate
 
Christopher Lieu
Consulting or Advisory Role - Flatiron Health (Inst); Pfizer (Inst)
Research Funding - Genentech (Inst)
 
Jonathan Loree
Consulting or Advisory Role - Advanced Accelerator Applications; AMGEN; BMS GmbH & Co. KG; GlaxoSmithKline; Ipsen; Merck; Pfizer; Sanofi
Research Funding - Personalis
 
Qian Shi
Consulting or Advisory Role - Abbvie; Agenus; BeOne Medicines; BMS; Exelixis; Genmab US, Inc; Hoosier Cancer Research Network; HopeAI, Inc; Mirati Therapeutics; Regeneron
Research Funding - BMS (Inst); Janssen (Inst); MPAACT (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst)